Cost-effectiveness of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis in Belarus, Georgia, Kazakhstan and the Republic of Moldova.

Allel K, Palmer T, Abou Jaoude GJ, Korotych O, Yedilbayev A, Vilc V, Corloteanu A, Macari M, Evghenia C, Laticevschi D, Shakhimurat-Shaimovich I, Anar-Saduakasovna R, Gulzhan-Elbrusovna T, Anatolievna-Ryazanet D, Shahrizada-Yergalymovna A, Yatskevich N, Skrahina A, Zhurkin D, Avaliani Z, Kiria N, Lomtadze N, Kiria N, Avaliani T, Khonelidze I, Danelia M, Maxim C, Haghparast-Bidgoli H, Skordis J

Open source

DOI: 10.1136/bmjgh-2024-018099
Published: 2025 Nov 8
Container: BMJ global health
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/bmjgh-2024-018099,
  title = {Cost-effectiveness of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis in Belarus, Georgia, Kazakhstan and the Republic of Moldova.},
  author = {Allel K and Palmer T and Abou Jaoude GJ and Korotych O and Yedilbayev A and Vilc V and Corloteanu A and Macari M and Evghenia C and Laticevschi D and Shakhimurat-Shaimovich I and Anar-Saduakasovna R and Gulzhan-Elbrusovna T and Anatolievna-Ryazanet D and Shahrizada-Yergalymovna A and Yatskevich N and Skrahina A and Zhurkin D and Avaliani Z and Kiria N and Lomtadze N and Kiria N and Avaliani T and Khonelidze I and Danelia M and Maxim C and Haghparast-Bidgoli H and Skordis J},
  year = {2025},
  journal = {BMJ global health},
  doi = {10.1136/bmjgh-2024-018099},
  url = {https://doi.org/10.1136/bmjgh-2024-018099}
}

RIS

TY  - JOUR
TI  - Cost-effectiveness of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis in Belarus, Georgia, Kazakhstan and the Republic of Moldova.
AU  - Allel K
AU  - Palmer T
AU  - Abou Jaoude GJ
AU  - Korotych O
AU  - Yedilbayev A
AU  - Vilc V
AU  - Corloteanu A
AU  - Macari M
AU  - Evghenia C
AU  - Laticevschi D
AU  - Shakhimurat-Shaimovich I
AU  - Anar-Saduakasovna R
AU  - Gulzhan-Elbrusovna T
AU  - Anatolievna-Ryazanet D
AU  - Shahrizada-Yergalymovna A
AU  - Yatskevich N
AU  - Skrahina A
AU  - Zhurkin D
AU  - Avaliani Z
AU  - Kiria N
AU  - Lomtadze N
AU  - Kiria N
AU  - Avaliani T
AU  - Khonelidze I
AU  - Danelia M
AU  - Maxim C
AU  - Haghparast-Bidgoli H
AU  - Skordis J
PY  - 2025
JO  - BMJ global health
DO  - 10.1136/bmjgh-2024-018099
UR  - https://doi.org/10.1136/bmjgh-2024-018099
ER  -

APA

K, A., T, P., GJ, A. J., O, K., A, Y., V, V., A, C., M, M., C, E., D, L., I, S., R, A., T, G., D, A., A, S., N, Y., A, S., D, Z., Z, A., N, K., N, L., N, K., T, A., I, K., M, D., C, M., H, H., & J, S. (2025). Cost-effectiveness of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis in Belarus, Georgia, Kazakhstan and the Republic of Moldova.. BMJ global health. https://doi.org/10.1136/bmjgh-2024-018099

Source records

pubmed · retrieved 2026-09-27T10:51:29.966Z
europe-pmc · retrieved 2026-09-27T10:51:29.972Z
doaj · retrieved 2026-09-27T10:51:29.982Z